Adiso
Adiso Therapeutics — Advancing Novel Therapies For Inflammatory Diseases
United States · Founded 2022 · $60.0M raised
- Employees
- 1–10
- Founded
- 2022
- Business Model
- B2B
- Website
- adisotx.com
- Total Funding
- $60.0M
- Last Round
- $60.0M SeedMar 2022
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Clinical-stage biotech developing novel therapies for inflammatory diseases.
Summary
Adiso is a Biotech company based in United States, founded in 2022. It has raised $60.0M in total across 1 round, most recently a $60.0M Seed round in Mar 2022. Investors include Morningside Group.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2022
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/adiso"><img src="https://indexed.vc/api/badge/company/adiso" alt="Adiso on Indexed.vc" width="260" height="76" /></a>